FundamentalVR has raised £16.4m to accelerate the transfer of medical skills and enhance surgical excellence through its medical simulation platform Fundamental Surgery.
The platform combines virtual reality and haptic capabilities through data, artificial intelligence and multimodal learning. Its patented HapticVRTM technology simulates the physical touch of surgical procedures, allowing users to experience the sights, sounds and physical sensations of real surgery.
The scalable and hardware-agnostic platform immerses users in a controlled learning environment that reduces surgical risk for patients.
Deployed in more than 30 countries, its simulations help life science, pharmaceutical and medical device companies drive medical innovation in disciplines ranging from ophthalmology to robotics and gene therapy.
The deal was led by EQT Life Sciences, which invested with LSP Health Economics Fund 2, and was joined by previous investors Downing Ventures. This will further grow the company in the US and bring its total funding to over $30 million.
“Our platform can provide step-by-step instruction from a procedure to a full operation, facilitating the transfer of surgical skills – which is why we’ve been enthusiastically adopted across the medical industry, from medical device manufacturers to pharmaceuticals,” says co-founder and CEO Richard Vincent.
“Our immersive environments transform the acquisition of surgical skills in a scalable, low-cost, multi-user way. We are excited to scale our vision of creating a barrier-free medical education environment.”
As part of the transactions, EQT Life Sciences’ Drew Burdon will join the board of directors.
